Li et al. (2018) discussed whether the upregulation of the neurotrophin IGF-1 and the HSP70 chaperone molecular pathway could suppress the mutant ataxin-3 protein toxicity in MSC-treated SCA3 mice [38]. The gene discussed is IGF1; the disease is Spinocerebellar ataxia type 3.